Skip to main content Help with accessibility Skip to main navigation

October 2020 updates to the website

The website has now been updated following October's LSCMMG

The following guidelines have been added/updated:

Antipsychotic - shared care guidance – update

The following Items will be ratified and added to the website following Joint Committee of CCGs (JCCCG) Meeting:

Dibotermin alfa (InductOs®) - for the treatment of acute tibia Gustilo-Anderson grade IIIB fractures in adults, as an adjunct to standard care using open fracture reduction and intramedullary unreamed nail fixation (licensed indication)

Dibotermin alfa (InductOs®) - for use outside of the licensed indication for the treatment of non-union long bone fractures

Rifaximin - Second line antibacterial treatment for the treatment of Small Intestinal Bacterial Overgrowth

Linezolid - Pneumonia, skin and soft-tissue infections

Vaco Cast Diabetic - Pneumonia, skin and soft-tissue infections

Psoriasis: LSCMMG Biologic and High Cost Drug Commissioning Pathway - Update

Over the Counter Items that Should not be Routinely Prescribed in Primary Care Policy - Update

Pneumococcal and Haemophilus type b / Meningococcal (Menitorix) group C Vaccines - Use in adults with low antibody levels

Melatonin - Melatonin Prolonged Release Tablets (Circadin®) for the Treatment of Rapid Eye Movement (REM) Sleep Behaviour Disorder (RBD) in Parkinson’s Disease

Linezolid - Pneumonia, skin and soft-tissue infections

Pregabalin - Treatment of GAD 

Domperidone - As a galactagogue for birth mothers and mothers of adopted babies

Oscillating Positive Expiratory Pressure Devices - For Non – Cystic Fibrosis Bronchiectasis